THROMBUS ON LEFT ATRIAL APPENDAGE OCCLUDER DEVICE: PERIPROCEDURAL CAUTION
نویسندگان
چکیده
منابع مشابه
Transesophageal echocardiographic diagnosis of left atrial appendage occluder device infection.
The safety and efficacy of a left atrial appendage closure device is currently under evaluation in a large-scale multi-center clinical trial. We report an initial case of left atrial appendage occluder device infection with Staphylococcus aureus; transesophageal echocardiography played a pivotal role in diagnosis and treatment.
متن کاملComplex left atrial appendage morphology and left atrial appendage thrombus formation in patients with atrial fibrillation.
BACKGROUND In patients with atrial fibrillation (AF), most thrombus forms in the left atrial appendage (LAA). However, the relation of LAA morphology with LAA thrombus is unknown. METHODS AND RESULTS We prospectively enrolled 633 consecutive patients who were candidates for catheter ablation for symptomatic drug-resistant AF. Transesophageal echocardiography (TEE) was performed to assess LAA ...
متن کاملLeft Atrial Appendage Thrombus Despite Anticoagulation.
The American College of Cardiology Foundation/American Heart Association task force on practice guidelines recommend therapeutic anticoagulation for at least 3 weeks prior to cardioversion in patients with atrial fibrillation of 48-hour duration or longer, or when the duration of atrial fibrillation is unknown. This case report demonstrates the presence of thrombi in the left atrial appendage d...
متن کاملDetection of left atrial appendage thrombus by cardiac computed tomography: a word of caution.
In this issue of iJACC, Martinez et al. (1) report their experience with cardiac computed tomography (CCT) to detect left atrial appendage thrombi in patients with atrial fibrillation undergoing pulmonary vein radiofrequency ablation. Atrial fibrillation is one of the most common cardiovascular disorders, carrying significant morbidity, including cardio-embolic stroke and heart failure. Slow fl...
متن کاملPreclinical evaluation of a new left atrial appendage occluder (Lifetech LAmbre™ device) in a canine model.
OBJECTIVES The study evaluated the feasibility and safety of a novel left atrial appendage (LAA) occluder (LAmbre™, Lifetech Scientific Corp., China) in canines. BACKGROUND Transcatheter LAA occlusion is comparable to warfarin in preventing atrial fibrillation-related strokes. METHODS Twenty-two healthy dogs (28 ± 3 kg) received LAmbre implants. The device is delivered by an 8-10 French she...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2013
ISSN: 0735-1097
DOI: 10.1016/s0735-1097(13)60353-8